HOUSTON--(BUSINESS WIRE)--July 17, 2006--Steven Rash, chairman and CEO of Power3 Medical Products, Inc. (PWRM.PK), a leading proteomics company that develops and commercializes early detection diagnostic tests for breast cancer and neurodegenerative diseases, will discuss his company's progress in developing blood-based early detection testing in an online radio interview available worldwide tomorrow (Tuesday).
